2020 annual financial data
Sarepta Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was 19.9%.
Operating income was -564,163,000 USD and net income was -554,128,000 USD.
Operating cash flow was 107,466,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 540,099,000 USD
- Operating income
- -564,163,000 USD
- Net income
- -554,128,000 USD
- Operating cash flow
- 107,466,000 USD